The writer is co-director of the Institute of Global Health Innovation at Imperial College London and chair of Pre-emptive Medicine and Health Security Initiative at Flagship Pioneering, the bioplatforms company that founded vaccines maker Moderna
本文作者是伦敦帝国理工学院(Imperial College London)manbetx app苹果 健康创新研究所(Institute of Global Health Innovation)联席主任，以及Flagship Pioneering的“预防医药和健康安全倡议”(Preemptive Medicine and Health Security Initiative)主席。Flagship Pioneering是一家生物平台企业，创建了疫苗制造商莫德纳(Moderna)
您已阅读9%（477字），剩余91%（4601字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。